PUBLISHED FOR OPPOSITION
on 26 Nov 2024
Last Applicant/ Owned by
Sanders Road Oxford Science Park
Oxford
GB
OX44GD
Serial Number
98107336 filed on 28th Jul 2023
Registration Number
N/A
Correspondent Address
Andrew D. Price
Filing Basis
1. intent to use
Disclaimer
NO DATA
MODITOPE
Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98107336
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 085846583013
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 26th Nov 2024 | PUBLISHED FOR OPPOSITION |
| 20th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 09th Oct 2024 | ASSIGNED TO LIE |
| 09th Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 09th Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 24th Jun 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 17th Apr 2024 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| 17th Apr 2024 | PRIORITY ACTION E-MAILED |